Sunosi

Active Ingredient(s): Solriamfetol
FDA Approved: * March 20, 2019
Pharm Company: * JAZZ PHARMA IRELAND LTD
Category: Narcolepsy

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Sunosi Overview

Solriamfetol, sold under the brand name Sunosi, is a medication used for the treatment of excessive sleepiness associated with narcolepsy and sleep apnea.[1] Common side effects include headache, nausea, anxiety, and trouble sleeping.[1] It is a norepinephrine–dopamine reuptake inhibitor (NDRI). It is derived from phenylalanine and its chemical name is (R)-2-amino-3-phenylpropylcarbamate hydrochloride.[2] The drug was discovered by a subsi...

Read more Sunosi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Solriamfetol

Recent Sunosi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Solriamfetol
  • Tablet: 150mg, 75mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Solriamfetol or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 May 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA